The FIU wireless network is something you expect from a billion-dollar company, not a microcap. Under-the-radar monster. NXXT PT $6.1. DYOR ⚡
$SGBX $CAVA
#XRP#TejRan#DoubleUp
NextNRG, Inc is gaining attention for good reason. +196% YoY, $65.8M YTD and multi-acre infrastructure deployments place it far ahead of typical microcaps. PT $2.50-$3.00 remains realistic upside.
$WULF $GOOG
#uzaksehir
Mainz Biomed N.V. gains a massive visibility boost as DoctorBox adds ColoAlert to its platform, putting CRC screening directly in users' hands. Digital adoption scales faster than any lab rollout can match 🚀
$GSIT $WULF
#FFTB#jonita
CRC early detection is a massive sector with growing political urgency. Mainz Biomed N.V being commercial already is a big edge. Microcap pricing won’t last - $1.10–$1.20 PT is well within reach.
$BULL $FNMA
#FFTB#CihAl
Market still pricing $MYNZ like a preclinical project despite >90% sensitivity and +33% YoY revenue. Overshoot risk to the upside is massive. PT $1.10–$1.20 feels like the first logical checkpoint.
$NVDA $CAVA
#XRP
$OSCR continues to position itself for a euphoric squeeze with over 100-150% upside possible…
Currently within a 3 year cup and handle with 2025 being a full consolidation year for $OSCR.
2026 will be the breakthrough year.
$45+ is the next upside target.
Don’t miss it…
$MYNZ pushing above the $1.04 mark with +5% pre-market strength sends a clear signal: buyers are stepping in early. With the 52-week range stretching up to 10.56, this rebound has serious room to expand if momentum continues.
$MSFT $BYND $INTC
#AfRam#shailenzo
$TSLA remains a strong buy, despite the recent pullback which simply filled gaps…
It’s clear $TSLA will soon have a $NVDA momentum and rally 200%+ within 14 months.
You will regret not taking advantage of the current prices.
$550+ incoming by January 2026.
Mark my words…